279:
262:
245:
228:
211:
29:
465:
Marker Gene
Technologies for an undisclosed amount. The acquisition of Marker Gene Technologies bring expertise in the areas of biology, organic synthesis and fluorescence chemistry. The team from MGT are experienced in the creation of detection tools that enable enhanced understanding of biological processes.
425:
On 12 September 2011, Abcam completed the purchase of Ascent
Scientific. Ascent Scientific was a company based in Bristol, United Kingdom that provided high-quality biochemical products that modulate the function of proteins for use in life science research. After outsourcing biochemical production,
464:
Abcam acquired Calico
Biolabs in January 2019. A year later, on 6 January 2020, Abcam announces the successful acquisition of Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences. On 4 March 2020, Abcam extend their assay and labelling capabilities by acquiring
394:
Since its inception in 1998, the company has diversified from carrying only antibodies. It supplies antibody related products such as immunoassays (e.g. SimpleStep ELISA Kits), peptides, proteins and protein detection products (e.g. immunohistochemistry (IHC) staining kits). Abcam also has a
390:
laboratory. The project had slowed because of problems finding quality antibody reagents that had honest and up-to-date information about their uses and limitations. This scenario provided the motivation to form an on-line service that would help themselves and researchers across the globe.
429:
On 19 April 2012, Abcam completed the purchase of
Epitomics. Epitomics was a privately held biotech company in Burlingame, California (US) and Hangzhou (China) that focused on the development, production, and distribution of rabbit
973:
460:
On 11 November 2015, Abcam announced the acquisition of AxioMx. AxioMx, based in
Branford, Connecticut (US), "provides a comprehensive custom recombinant antibody discovery and development services platform".
349:
is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in
Research and Development (R&D). Abcam was listed on the
414:
platforms and high performance monoclonal antibodies. It was founded in 2004 with the mission of advancing mitochondrial research and developing products that support critical research in cancer,
1045:
758:
402:
announced that it had entered into a definitive agreement to acquire Abcam for approximately $ 5.7 billion at $ 24 per share in cash. The acquisition was completed on
December 6.
732:
410:
In May 2011, Abcam announced the acquisition of MitoSciences, a privately held biotech company based in Eugene, Oregon (US). The company produced and distributed
1035:
1050:
560:
1065:
655:
437:
On 20 January 2015, Abcam announced the acquisition of
Firefly BioWorks, a privately held company based in Cambridge, Massachusetts (US), for
395:
portfolio of non-antibody related products such as biochemicals, cellular assays, and epigenetics kits (e.g. FirePlex
Multiplex miRNA Kits).
769:
681:
1055:
707:
524:
1060:
974:"Abcam announces successful acquisition of Expedeon's Proteomics and Immunology business, enhancing its conjugation capability"
917:
794:
947:
1040:
450:
630:
574:
220:
987:
892:
599:
485:
1070:
73:
378:, with the idea of making it easier for research scientists to buy antibodies across the web. Milner was a
179:
156:
866:
850:
848:
Staff (15 February 2015). "Abcam Buys
Firefly for $ 28M to Broaden Multiplex Analysis Capabilities".
387:
546:
431:
379:
355:
449:, based on a microfabrication technology developed by Daniel Pregibon and Patrick Doyle at
8:
893:"Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership"
419:
399:
359:
305:
819:
733:"Abcam Completes $ 6M Takeover of Mitochondrial Research Tools Specialist MitoSciences"
442:
415:
925:
271:
490:
371:
138:
438:
375:
297:
143:
370:
The company was founded in 1998 by Jonathan Milner with co-founders professor
1029:
101:
96:
64:
411:
457:
from RNA and crude biofluid. Firefly was rebranded to FirePlex in 2016.
486:"Abcam Limited overview - Find and update company information - GOV.UK"
237:
56:
607:
446:
161:
454:
426:
the Bristol site and manufacturing facilities were closed in 2017.
193:
453:, and launched its first products for the multiplex detection of
351:
79:
1046:
Companies formerly listed on the Alternative Investment Market
383:
254:
28:
1018:
519:
517:
515:
513:
511:
509:
506:
820:"BRIEF-Abcam to buy Firefly Bioworks for 18.5 mln stg"
631:"Danaher to buy Abcam in deal valued at $ 5.7 billion"
527:. US Securities and Exchange Commission. 20 March 2023
332:
434:
for biomedical research and diagnostic applications.
795:"Abcam to buy Epitomics of San Francisco for $ 170M"
382:
studying the newly discovered breast cancer protein
323:
1027:
480:
478:
561:"Danaher Completes $ 5.7B Acquisition of Abcam"
575:"Abcam - the next giant of the Life Sciences?"
1036:Biotechnology companies of the United Kingdom
854:(paper). Vol. 35, no. 4. p. 6.
475:
851:Genetic Engineering & Biotechnology News
600:"Abcam plc investor relations - Abcam story"
1051:Biotechnology companies established in 1998
27:
988:"Abcam Acquires Marker Gene Technologies"
682:"Danaher to Acquire Abcam - Aug 28, 2023"
708:"Danaher Completes Acquisition of Abcam"
1066:Companies formerly listed on the Nasdaq
441:18,500,000. Firefly developed a novel
198:Kits and assays for biological research
1028:
864:
737:Genetic Engineering & Biology News
628:
525:"Abcam 2022 Annual Report (Form 20-F)"
847:
843:
841:
451:Massachusetts Institute of Technology
918:"Corporate Overview - Axiomxinc.com"
725:
563:. Contract Pharma. 6 December 2023.
547:"ABCAM share price (ABCM) - Nasdaq"
13:
838:
14:
1082:
1010:
629:Mishra, Manas (28 August 2023).
278:
277:
261:
260:
244:
243:
227:
226:
210:
209:
980:
966:
948:"Abcam acquires Calico Biolabs"
940:
910:
885:
865:Dutton, Gail (30 August 2018).
858:
812:
787:
751:
700:
405:
1056:1998 establishments in England
867:"Wisdom of the Antibody Crowd"
759:"Abcam H1 2018 Interim Report"
674:
648:
622:
592:
567:
553:
539:
445:platform for the detection of
1:
1061:2023 mergers and acquisitions
468:
16:British biotechnology company
1041:Companies based in Cambridge
7:
157:Cambridge Biomedical Campus
116:; 26 years ago
10:
1087:
656:"Danaher to Acquire Abcam"
365:
358:until it was acquired by
315:
296:
286:
269:
252:
235:
218:
205:
186:
172:
152:
128:
110:
89:
62:
52:
42:Abcam Limited (1998–2005)
35:
26:
873:. Mary Ann Liebert, Inc
380:postdoctoral researcher
231:£(10.1) million (2022)
952:Manufacturing Chemist
432:monoclonal antibodies
356:London Stock Exchange
282:£726.9 million (2022)
265:£1,057 million (2022)
248:£(8.5) million (2022)
214:£361.7 million (2022)
45:Abcam plc (2005–2023)
1071:Danaher subsidiaries
660:Life Sciences Europe
388:Cambridge University
420:metabolic disorders
400:Danaher Corporation
398:On 28 August 2023,
360:Danaher Corporation
306:Danaher Corporation
288:Number of employees
194:Research antibodies
23:
494:. 12 February 1998
21:
928:on 22 August 2015
897:Cambridge Network
826:. 21 January 2015
416:neurodegeneration
344:
343:
1078:
1022:
1021:
1019:Official website
1004:
1003:
1001:
999:
984:
978:
977:
970:
964:
963:
961:
959:
944:
938:
937:
935:
933:
924:. Archived from
914:
908:
907:
905:
903:
889:
883:
882:
880:
878:
862:
856:
855:
845:
836:
835:
833:
831:
816:
810:
809:
807:
805:
791:
785:
784:
782:
780:
774:
768:. Archived from
766:www.abcamplc.com
763:
755:
749:
748:
746:
744:
729:
723:
722:
720:
718:
704:
698:
697:
695:
693:
688:. 28 August 2023
678:
672:
671:
669:
667:
662:. 28 August 2023
652:
646:
645:
643:
641:
626:
620:
619:
617:
615:
606:. Archived from
604:www.abcamplc.com
596:
590:
589:
587:
585:
579:Business Insider
571:
565:
564:
557:
551:
550:
543:
537:
536:
534:
532:
521:
504:
503:
501:
499:
482:
337:
334:
328:
325:
281:
280:
274:
264:
263:
257:
247:
246:
230:
229:
221:Operating income
213:
212:
124:
122:
117:
31:
24:
20:
1086:
1085:
1081:
1080:
1079:
1077:
1076:
1075:
1026:
1025:
1017:
1016:
1013:
1008:
1007:
997:
995:
986:
985:
981:
972:
971:
967:
957:
955:
946:
945:
941:
931:
929:
916:
915:
911:
901:
899:
891:
890:
886:
876:
874:
863:
859:
846:
839:
829:
827:
818:
817:
813:
803:
801:
793:
792:
788:
778:
776:
772:
761:
757:
756:
752:
742:
740:
731:
730:
726:
716:
714:
706:
705:
701:
691:
689:
686:www.danaher.com
680:
679:
675:
665:
663:
654:
653:
649:
639:
637:
627:
623:
613:
611:
598:
597:
593:
583:
581:
573:
572:
568:
559:
558:
554:
545:
544:
540:
530:
528:
523:
522:
507:
497:
495:
491:Companies House
484:
483:
476:
471:
443:multiplex assay
408:
386:in Kouzarides'
372:Tony Kouzarides
368:
340:
331:
322:
311:
289:
270:
253:
240:
223:
201:
178:Markus Lusser (
175:
168:
164:
148:
139:Tony Kouzarides
135:Jonathan Milner
120:
118:
115:
106:
85:
67:
48:
17:
12:
11:
5:
1084:
1074:
1073:
1068:
1063:
1058:
1053:
1048:
1043:
1038:
1024:
1023:
1012:
1011:External links
1009:
1006:
1005:
994:. 4 March 2020
979:
965:
939:
909:
884:
857:
837:
811:
786:
775:on 10 May 2018
750:
724:
699:
673:
647:
621:
610:on 8 June 2016
591:
566:
552:
538:
505:
473:
472:
470:
467:
407:
404:
376:David Cleevely
367:
364:
342:
341:
339:
338:
329:
319:
317:
313:
312:
310:
309:
308:(2023–present)
302:
300:
294:
293:
290:
287:
284:
283:
275:
267:
266:
258:
250:
249:
241:
236:
233:
232:
224:
219:
216:
215:
207:
203:
202:
200:
199:
196:
190:
188:
184:
183:
176:
173:
170:
169:
166:
160:
154:
150:
149:
147:
146:
144:David Cleevely
141:
136:
132:
130:
126:
125:
112:
108:
107:
105:
104:
99:
93:
91:
87:
86:
84:
83:
77:
70:
68:
63:
60:
59:
54:
50:
49:
47:
46:
43:
39:
37:
33:
32:
15:
9:
6:
4:
3:
2:
1083:
1072:
1069:
1067:
1064:
1062:
1059:
1057:
1054:
1052:
1049:
1047:
1044:
1042:
1039:
1037:
1034:
1033:
1031:
1020:
1015:
1014:
993:
989:
983:
975:
969:
953:
949:
943:
927:
923:
922:Axiomxinc.com
919:
913:
898:
894:
888:
872:
868:
861:
853:
852:
844:
842:
825:
821:
815:
800:
796:
790:
771:
767:
760:
754:
739:. 24 May 2011
738:
734:
728:
713:
709:
703:
687:
683:
677:
661:
657:
651:
636:
632:
625:
609:
605:
601:
595:
580:
576:
570:
562:
556:
548:
542:
526:
520:
518:
516:
514:
512:
510:
493:
492:
487:
481:
479:
474:
466:
462:
458:
456:
452:
448:
444:
440:
435:
433:
427:
423:
421:
417:
413:
403:
401:
396:
392:
389:
385:
381:
377:
373:
363:
361:
357:
353:
348:
347:Abcam Limited
336:
330:
327:
321:
320:
318:
314:
307:
304:
303:
301:
299:
295:
291:
285:
276:
273:
268:
259:
256:
251:
242:
239:
234:
225:
222:
217:
208:
204:
197:
195:
192:
191:
189:
185:
181:
177:
171:
163:
158:
155:
151:
145:
142:
140:
137:
134:
133:
131:
127:
113:
109:
103:
102:Life sciences
100:
98:
97:Biotechnology
95:
94:
92:
88:
81:
78:
75:
72:
71:
69:
66:
61:
58:
55:
51:
44:
41:
40:
38:
34:
30:
25:
22:Abcam Limited
19:
996:. Retrieved
991:
982:
968:
958:16 September
956:. Retrieved
954:. HPCi Media
951:
942:
930:. Retrieved
926:the original
921:
912:
900:. Retrieved
896:
887:
877:16 September
875:. Retrieved
870:
860:
849:
828:. Retrieved
823:
814:
802:. Retrieved
798:
789:
777:. Retrieved
770:the original
765:
753:
741:. Retrieved
736:
727:
715:. Retrieved
711:
702:
690:. Retrieved
685:
676:
666:27 September
664:. Retrieved
659:
650:
638:. Retrieved
634:
624:
612:. Retrieved
608:the original
603:
594:
582:. Retrieved
578:
569:
555:
541:
529:. Retrieved
496:. Retrieved
489:
463:
459:
436:
428:
424:
409:
406:Acquisitions
397:
393:
369:
346:
345:
292:1,760 (2022)
272:Total equity
255:Total assets
153:Headquarters
53:Company type
18:
932:21 December
902:21 December
830:21 December
804:21 December
799:MarketWatch
743:21 December
717:12 December
712:PR Newswire
498:13 February
412:immunoassay
82:: ABCM
1030:Categories
469:References
447:biomarkers
238:Net income
174:Key people
76:: ABC
57:Subsidiary
998:6 October
992:GenomeWeb
692:28 August
640:28 August
531:12 August
362:in 2023.
180:president
162:Cambridge
65:Traded as
455:microRNA
354:and the
333:abcamplc
187:Products
129:Founders
90:Industry
36:Formerly
824:Reuters
614:16 June
584:16 June
366:History
316:Website
206:Revenue
119: (
111:Founded
635:Nasdaq
418:, and
352:Nasdaq
298:Parent
80:Nasdaq
779:9 May
773:(PDF)
762:(PDF)
384:BRCA2
324:abcam
1000:2020
960:2019
934:2015
904:2015
879:2019
832:2015
806:2015
781:2018
745:2015
719:2023
694:2023
668:2023
642:2023
616:2016
586:2016
533:2023
500:2024
374:and
335:.com
326:.com
121:1998
114:1998
871:GEN
74:AIM
1032::
990:.
950:.
920:.
895:.
869:.
840:^
822:.
797:.
764:.
735:.
710:.
684:.
658:.
633:.
602:.
577:.
508:^
488:.
477:^
422:.
167:UK
165:,
159:,
1002:.
976:.
962:.
936:.
906:.
881:.
834:.
808:.
783:.
747:.
721:.
696:.
670:.
644:.
618:.
588:.
549:.
535:.
502:.
439:£
182:)
123:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
